Indications for the endoscopic lumbar interbody fusion
The EndoLIF® On-Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. Degenerative disc disease is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These patients may also have up to Grade I spondylolisthesis at the involved level(s).These patients may have had previous non-fusion spinal surgery at the involved spinal level(s). EndoLIF®On-Cages are to be used with autogenous bone and implanted via a posterior or posterolateral approach. The EndoLIF® On-Cage is to be used with supplemental FDA cleared fixation. Patients should have at least six months of non-operative treatment prior to treatment with an EndoLIF® On-Cage.